Project

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Ac-cess

Ongoing - recruitment active · 2022 until 2027

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2022
End Date
2027
Financing
Others
Labels
other tumors
Brief description/objective

SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.